These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 29904998)
21. Performance of formulas for estimating glomerular filtration rate in Indigenous Australians with and without Type 2 diabetes: the eGFR Study. Maple-Brown LJ; Ekinci EI; Hughes JT; Chatfield M; Lawton PD; Jones GR; Ellis AG; Sinha A; Cass A; Hoy WE; O'Dea K; Jerums G; MacIsaac RJ; Diabet Med; 2014 Jul; 31(7):829-38. PubMed ID: 24598003 [TBL] [Abstract][Full Text] [Related]
22. Performance of urinary vitamin D-binding protein in diabetic kidney disease: a meta-analysis. Chen H; Ni L; Wu X Ren Fail; 2023; 45(2):2256415. PubMed ID: 37870829 [No Abstract] [Full Text] [Related]
23. Estimated glomerular filtration rate in patients with type 2 diabetes mellitus. Fontela PC; Winkelmann ER; Ott JN; Uggeri DP Rev Assoc Med Bras (1992); 2014; 60(6):531-7. PubMed ID: 25650852 [TBL] [Abstract][Full Text] [Related]
24. Effects of uric acid-lowering therapy on the progression of chronic kidney disease: a systematic review and meta-analysis. Liu X; Zhai T; Ma R; Luo C; Wang H; Liu L Ren Fail; 2018 Nov; 40(1):289-297. PubMed ID: 29619870 [TBL] [Abstract][Full Text] [Related]
25. High-normal serum uric acid is associated with albuminuria and impaired glomerular filtration rate in Chinese type 2 diabetic patients. Cai XL; Han XY; Ji LN Chin Med J (Engl); 2011 Nov; 124(22):3629-34. PubMed ID: 22340215 [TBL] [Abstract][Full Text] [Related]
26. Improved clinical trial enrollment criterion to identify patients with diabetes at risk of end-stage renal disease. Yamanouchi M; Skupien J; Niewczas MA; Smiles AM; Doria A; Stanton RC; Galecki AT; Duffin KL; Pullen N; Breyer MD; Bonventre JV; Warram JH; Krolewski AS Kidney Int; 2017 Jul; 92(1):258-266. PubMed ID: 28396115 [TBL] [Abstract][Full Text] [Related]
27. Effects of valsartan combined with α-lipoic acid on renal function in patients with diabetic nephropathy: a systematic review and meta-analysis. Sun F; Jiang D; Cai J BMC Endocr Disord; 2021 Aug; 21(1):178. PubMed ID: 34465338 [TBL] [Abstract][Full Text] [Related]
28. Cystatin C is a more sensitive marker than creatinine for the estimation of GFR in type 2 diabetic patients. Mussap M; Dalla Vestra M; Fioretto P; Saller A; Varagnolo M; Nosadini R; Plebani M Kidney Int; 2002 Apr; 61(4):1453-61. PubMed ID: 11918752 [TBL] [Abstract][Full Text] [Related]
30. Higher serum betatrophin level in type 2 diabetes subjects is associated with urinary albumin excretion and renal function. Chen CC; Susanto H; Chuang WH; Liu TY; Wang CH Cardiovasc Diabetol; 2016 Jan; 15():3. PubMed ID: 26739836 [TBL] [Abstract][Full Text] [Related]
31. Diabetic hypouricemia as an indicator of clinical nephropathy. Shichiri M; Iwamoto H; Marumo F Am J Nephrol; 1990; 10(2):115-22. PubMed ID: 2190467 [TBL] [Abstract][Full Text] [Related]
32. Kidney Disease End Points in a Pooled Analysis of Individual Patient-Level Data From a Large Clinical Trials Program of the Dipeptidyl Peptidase 4 Inhibitor Linagliptin in Type 2 Diabetes. Cooper ME; Perkovic V; McGill JB; Groop PH; Wanner C; Rosenstock J; Hehnke U; Woerle HJ; von Eynatten M Am J Kidney Dis; 2015 Sep; 66(3):441-9. PubMed ID: 25960304 [TBL] [Abstract][Full Text] [Related]
34. Vitamin D analogue therapy, cardiovascular risk and kidney function in people with Type 1 diabetes mellitus and diabetic nephropathy: a randomized trial. Joergensen C; Tarnow L; Goetze JP; Rossing P Diabet Med; 2015 Mar; 32(3):374-81. PubMed ID: 25307511 [TBL] [Abstract][Full Text] [Related]
35. Protein Diet Restriction Slows Chronic Kidney Disease Progression in Non-Diabetic and in Type 1 Diabetic Patients, but Not in Type 2 Diabetic Patients: A Meta-Analysis of Randomized Controlled Trials Using Glomerular Filtration Rate as a Surrogate. Rughooputh MS; Zeng R; Yao Y PLoS One; 2015; 10(12):e0145505. PubMed ID: 26710078 [TBL] [Abstract][Full Text] [Related]
36. Antioxidant for treatment of diabetic nephropathy: A systematic review and meta-analysis. Kandhare AD; Mukherjee A; Bodhankar SL Chem Biol Interact; 2017 Dec; 278():212-221. PubMed ID: 29108777 [TBL] [Abstract][Full Text] [Related]
37. [Serum uric acid level in type 1 and type 2 diabetic patients]. Zazgornik J; Biesenbach G; Janko O; Grafinger P; Kaiser W; Stuby U; Hubmann R Wien Med Wochenschr; 1996; 146(5):102-4. PubMed ID: 8686325 [TBL] [Abstract][Full Text] [Related]
38. Tocotrienol-Rich Vitamin E from Palm Oil (Tocovid) and Its Effects in Diabetes and Diabetic Nephropathy: A Pilot Phase II Clinical Trial. Tan SMQ; Chiew Y; Ahmad B; Kadir KA Nutrients; 2018 Sep; 10(9):. PubMed ID: 30227659 [TBL] [Abstract][Full Text] [Related]
39. Protein restriction, glomerular filtration rate and albuminuria in patients with type 2 diabetes mellitus: a randomized trial. Pijls LT; de Vries H; van Eijk JT; Donker AJ Eur J Clin Nutr; 2002 Dec; 56(12):1200-7. PubMed ID: 12494305 [TBL] [Abstract][Full Text] [Related]
40. Effectiveness of antiplatelet drugs for the prevention of diabetic nephropathy: A meta-analysis of randomized controlled trials . Chen G; Huang W; Hong S; Li X; Su B; Li X; Tang S Clin Nephrol; 2018 Dec; 90(6):419-426. PubMed ID: 30378535 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]